Background: Bee bread is a fermented pollen-derived material containing nutrients and phytochemicals, but its effects on diabetic liver injury remain uncertain. Objective: To examine hepatic biochemical indices and qualitative liver morphology in streptozotocin–nicotinamide-induced diabetic male rats receiving ethanolic bee bread extract. Methods: Six experimental groups included non-diabetic and diabetic controls, a metformin comparator (100 mg/kg), and groups coded 150BB, 300BB, and 600BB. Treatment was administered orally for three weeks. Group-level biochemical results were available for 27 rats (four or five per group). Seven serum analytes were assessed, and liver sections were examined histologically. Exploratory one-way ANOVA was calculated from reported group sizes, means, and standard deviations, with adjustment across seven endpoints. Results: AST differed nominally among groups (F [5, 21] = 4.18, p = .0086) but not after Bonferroni adjustment (p = .0602). ALT, ALP, total protein, albumin, direct bilirubin, and total bilirubin did not show significant omnibus differences (all p > .05). Histological appearances varied; a section from the 600BB group showed comparatively preserved architecture, but animal-level histological scores were unavailable. No mortality was recorded during the documented 24-hour observations at 2,000 and 5,000 mg/kg. Conclusions: The available data do not demonstrate hepatoprotection or establish toxicological safety. Unresolved animal counts, uncertainty about one administered dose, incomplete extract documentation, and limited assay verification constrain interpretation.
No takes yet. Share an insight, caveat, or question.
Bello et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: